 MediciNova Inc NASDAQ: MNOV will conduct a mouse study to investigate the efficacy of MN-166 ibudilast in a murine model of chlorine-induced lung injury and lethality. After mice are exposed to chlorine gas and treated with MN-166 ibudilast or control, the study will evaluate survival, clinical outcomes, body weights, lung weights, and upper respiratory tract histopathology. 